Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma

NCT ID: NCT05174117

Last Updated: 2021-12-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

57 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-01

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this experiment is to study the alleviating effects and side effects of different laser irradiation doses on esophageal stricture of esophageal cancer in order to find the appropriate dose of light.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Photodynamic therapy (PDT) is one of the effective means for the control of esophageal stenosis in advanced esophageal cancer, among which the dose intensity of laser irradiation is one of the factors affecting the efficacy. This study aims to pursue the appropriate dose of light.

Aim: To compare the efficacy and safety of two groups of different laser irradiation doses for advanced esophageal cancer and esophageal stricture.

Methods: Fifty-seven patients were recruited for this study and randomly divided into two groups: single irradiation group and reirradiation group.Single irradiation group: 46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Double irradiation group: 46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.

Primary endpoints: ORR rates at 1 and 3 months, the quality of life

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophagus Cancer

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Esophagus Cancer Photodynamics Therapy Laser dose

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

single irradiation group

46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2

Group Type EXPERIMENTAL

single irradiation

Intervention Type COMBINATION_PRODUCT

46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2

Double irradiation group

46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.

Group Type ACTIVE_COMPARATOR

Double irradiation

Intervention Type COMBINATION_PRODUCT

46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

single irradiation

46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2

Intervention Type COMBINATION_PRODUCT

Double irradiation

46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* esophagus cancer
* 18-80 years old
* grade 3-4 dysphagia (Stoller classification)
* Non-eradicative second-line treatment

Exclusion Criteria

* Ulcerative tumor
* Esophageal stenosis caused by radiotherapy
* Survival is less than 3 months
* Patients known to be allergic to photosensitizers
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Affiliated Hospital of Henan University of Science and Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Shegan Gao, MD, PhD

Role: STUDY_CHAIR

The First Affiliated Hospital of Clinical Medicine of Henan University of Science and Technology

Tanyou Shan, MD, PhD

Role: STUDY_DIRECTOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Caihong Dong, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Wanying Li, MD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Jiachun Sun, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Mengxi Zhang, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Xiaozhi Yuan, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology

Luoyang, Henan, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shegan Gao, MD, PhD

Role: CONTACT

Phone: 18638859977

Email: [email protected]

Tanyou Shan, MD, PhD

Role: CONTACT

Phone: 18537976669

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Zeng R, Liu C, Li L, Cai X, Chen R, Li Z. Clinical Efficacy of HiPorfin Photodynamic Therapy for Advanced Obstructive Esophageal Cancer. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820930335. doi: 10.1177/1533033820930335.

Reference Type BACKGROUND
PMID: 32578508 (View on PubMed)

Yoon HY, Cheon YK, Choi HJ, Shim CS. Role of photodynamic therapy in the palliation of obstructing esophageal cancer. Korean J Intern Med. 2012 Sep;27(3):278-84. doi: 10.3904/kjim.2012.27.3.278. Epub 2012 Sep 1.

Reference Type BACKGROUND
PMID: 23019392 (View on PubMed)

Liu H, Liu Y, Wang L, Ruan X, Wang F, Xu D, Zhang J, Jia X, Liu D. Evaluation on Short-Term Therapeutic Effect of 2 Porphyrin Photosensitizer-Mediated Photodynamic Therapy for Esophageal Cancer. Technol Cancer Res Treat. 2019 Jan 1;18:1533033819831989. doi: 10.1177/1533033819831989.

Reference Type BACKGROUND
PMID: 30885065 (View on PubMed)

Lee HH, Choi MG, Hasan T. Application of photodynamic therapy in gastrointestinal disorders: an outdated or re-emerging technique? Korean J Intern Med. 2017 Jan;32(1):1-10. doi: 10.3904/kjim.2016.200. Epub 2017 Jan 1.

Reference Type BACKGROUND
PMID: 28049283 (View on PubMed)

Yano T, Minamide T, Takashima K, Nakajo K, Kadota T, Yoda Y. Clinical Practice of Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer. J Clin Med. 2021 Jun 24;10(13):2785. doi: 10.3390/jcm10132785.

Reference Type RESULT
PMID: 34202917 (View on PubMed)

National Health Commission Of The People's Republic Of China. Chinese guidelines for diagnosis and treatment of esophageal carcinoma 2018 (English version). Chin J Cancer Res. 2019 Apr;31(2):223-258. doi: 10.21147/j.issn.1000-9604.2019.02.01. No abstract available.

Reference Type RESULT
PMID: 31156297 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECPDT-001

Identifier Type: -

Identifier Source: org_study_id